102940 — Kolon Life Science Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Market Cap
KR₩331bn
Enterprise Value
KR₩445bn
Revenue
KR₩161bn

Annual balance sheet for Kolon Life Science, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	15,031	27,910	6,371	7,480	12,417
Net Total Accounts Receivable
Net Total Receivables	22,647	20,304	30,029	25,634	37,808
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	100,563	98,021	110,184	105,045	102,055
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	141,893	131,481	125,960	123,138	115,076
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	248,338	234,658	314,118	309,436	419,563
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	145,152	95,469	109,578	128,341	206,255
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	190,381	135,248	146,395	171,764	270,225
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Total Equity	57,957	99,410	167,723	137,672	149,338
Total Liabilities & Shareholders' Equity	248,338	234,658	314,118	309,436	419,563
Total Common Shares Outstanding